Literature DB >> 8683940

Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.

K J Daniels1, H C Boldt, J A Martin, L M Gardner, M Meyer, R Folberg.   

Abstract

Choroidal and ciliary body melanomas disseminate exclusively by a hematogenous route because there are no lymphatics inside the eye. Although angiogenesis is an absolute precondition for metastasis in this tumor system, not all morphologic expressions of tumor angiogenesis are associated with metastasis from choroidal and ciliary body melanomas. Specifically, the remodeling of the microcirculation to form vascular networks is very strongly associated with metastasis. Type VI collagen is upregulated in tissue remodeling and the generation of tissue patterns and is either not present in the normal choroid or present at very low levels. This study was designed to investigate the possible expression of type VI collagen in the stroma of choroidal and ciliary body melanomas. Type VI collagen was detected in tissue sections from five primary choroidal melanomas and three melanomas involving the choroid and ciliary body in the subendothelial compartment of the microcirculation and in avascular areas by immunohistochemistry. Melanoma cell lines were established from each of these tumors. Cultured melanoma cells invaded into type I collagen gels and expressed type VI collagen by immunohistochemistry. Using specific primers for human type VI collagen, the expected band size (413 base pairs) was isolated from one of the cell lines by reverse transcriptase PCR. The presence of type VI collagen in the melanoma tumor stroma reflects active remodeling of the uveal extracellular matrix microenvironment by the melanoma cells themselves. Before the formation of the microvasculature, the expression of type VI collagen and of the other matrix components, such as hyaluronan, to which it binds, may erect a scaffold permitting the formation of higher order stromal patterns such as vascular networks. These stromal patterns, which are markers of tumor progression, may be detectable clinically by a specialized form of ultrasonography that detects backscatterers of the same dimension as tissue compartments encircled by vascular loops in networks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683940

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  30 in total

Review 1.  Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?

Authors:  M J Bissell
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  Vasculogenic mimicry: how convincing, how novel, and how significant?

Authors:  D M McDonald; L Munn; R K Jain
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

3.  Reassessment of the PAS patterns in uveal melanoma.

Authors:  A J Foss; R A Alexander; J L Hungerford; A L Harris; I A Cree; S Lightman
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

4.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Authors:  Vladimír Cermák; Jan Kosla; Jirí Plachý; Katerina Trejbalová; Jirí Hejnar; Michal Dvorák
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

5.  Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.

Authors:  Amy Y Lin; Zhuming Ai; Sang-Chul Lee; Peter Bajcsy; Jacob Pe'er; Lu Leach; Andrew J Maniotis; Robert Folberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-03

6.  Modeling human choroidal melanoma xenograft growth in immunocompromised rodents to assess treatment efficacy.

Authors:  Rod D Braun; Kerry S Vistisen
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

7.  Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.

Authors:  S R Boyd; D S W Tan; L de Souza; M H Neale; N E Myatt; R A Alexander; M Robb; J L Hungerford; I A Cree
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

8.  Expression of VLA-2, VLA-3, and alpha(v) integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic value.

Authors:  G Anastassiou; H Schilling; S Djakovic; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

9.  Parthenolide inhibits the proliferation and induces the apoptosis of human uveal melanoma cells.

Authors:  Song-Tian Che; Li Bie; Xu Li; Hui Qi; Peng Yu; Ling Zuo
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

Review 10.  Authenticating cell lines in ophthalmic research laboratories.

Authors:  Robert Folberg; Shrihari S Kadkol; Shahar Frenkel; Klara Valyi-Nagy; Martine J Jager; Jacob Pe'er; Andrew J Maniotis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.